Developing New Treatments
Age Related Macular Degeneration (AMD) is the leading cause of blindness in the UK. This condition strikes those over 50 and blinds some 43,000 people a year in the UK alone.
Read
More Funding Research
This is the first trial designed to prevent PACG. If this study shows that there is a reduction in the number of cases of glaucoma in the people subjected to the ultrasound screening and laser treatment, it will have great implications for the management of blindness due to glaucoma throughout Asia. It may be possible to prevent glaucoma using a simple screening test and one-off laser treatment, both of which can be performed in the local community. The equipment is portable and easy to use, and the test can be safely performed by non-medical personnel.In addition to preventing the blinding effects of glaucoma, this would alleviate the need for more complicated treatment of glaucoma, such as surgery (which can have serious complications) and eye drops, both of which require regular follow-up of patients and are expensive and often financially impossible in developing countries.
Given that more than 60% of the world's population live in Asia, a safe, simple intervention such as this could make a very real impact on global glaucoma blindness.
We focus on funding research, including
Fellowships,
which has the potential to make breakthroughs in understanding and treating
currently incurable eye diseases, and on operational research to improve
best practice and delivery of eye care services.
Screening for Glaucoma
This is the first trial designed to prevent PACG. If this study shows that there is a reduction in the number of cases of glaucoma in the people subjected to the ultrasound screening and laser treatment, it will have great implications for the management of blindness due to glaucoma throughout Asia. It may be possible to prevent glaucoma using a simple screening test and one-off laser treatment, both of which can be performed in the local community. The equipment is portable and easy to use, and the test can be safely performed by non-medical personnel.In addition to preventing the blinding effects of glaucoma, this would alleviate the need for more complicated treatment of glaucoma, such as surgery (which can have serious complications) and eye drops, both of which require regular follow-up of patients and are expensive and often financially impossible in developing countries.
Given that more than 60% of the world's population live in Asia, a safe, simple intervention such as this could make a very real impact on global glaucoma blindness.
Dr Jennifer Yip examines a patient
